Syntax Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$225K Buy
1,446
+5
+0.3% +$825 0.2% 148
2023
Q2
$239K Sell
1,441
-137
-9% -$22.1K 0.19% 145
2023
Q1
$245K Buy
1,578
+198
+14% +$32K 0.19% 164
2022
Q4
$244K Sell
1,380
-173
-11% -$29.9K 0.2% 138
2022
Q3
$254K Buy
1,553
+156
+11% +$26.4K 0.22% 100
2022
Q2
$248K Buy
1,397
+44
+3% +$7.84K 0.21% 128
2022
Q1
$240K Sell
1,353
-216
-14% -$36.8K 0.2% 159
2021
Q4
$268K Buy
+1,569
New +$257K 0.2% 156

Other funds holding JNJ

Syntax Advisors's JNJ Position: Q3 2023 in Review

Syntax Advisors increased its Johnson & Johnson (JNJ) stake by 0.35% in Q3 2023, buying an estimated $825 and bringing the position to 1,446 shares worth $225K. The position accounts for 0.2% of the portfolio, ranked #148.

Syntax Advisors first reported a position in JNJ in Q4 2021 and has held it in 8 quarters since. The position peaked at $268K in Q4 2021. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Syntax Advisors held 1,446 shares of Johnson & Johnson worth $225K as of Q3 2023.
  • Syntax Advisors bought 5 Johnson & Johnson shares in Q3 2023, an estimated $825.
  • Johnson & Johnson made up 0.2% of Syntax Advisors's portfolio in Q3 2023, its #148 holding.
  • Syntax Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Johnson & Johnson position peaked at $268K in Q4 2021.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.